Early Phase II Trials for Cocaine Medication Development - 1

NCT00000317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Cocaine-Related Disorders
Substance-Related Disorders

Interventions

DRUG: Risperidone
DRUG: Placebo
BEHAVIORAL: Relapse prevention counseling

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]
[object Object]